These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20101130)

  • 1. Femoral cortical stress lesions in long-term bisphosphonate therapy: a herald of impending fracture?
    Koh JS; Goh SK; Png MA; Kwek EB; Howe TS
    J Orthop Trauma; 2010 Feb; 24(2):75-81. PubMed ID: 20101130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of incomplete atypical femoral fractures in patients after a prolonged and variable course of bisphosphonate therapy-a long-term radiological follow-up.
    Png MA; Mohan PC; Koh JSB; Howe CY; Howe TS
    Osteoporos Int; 2019 Dec; 30(12):2417-2428. PubMed ID: 31435684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term radiographic follow-up of bisphosphonate-associated atypical femur fractures.
    Favinger JL; Hippe D; Ha AS
    Skeletal Radiol; 2016 May; 45(5):627-33. PubMed ID: 26880003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subtrochanteric stress fractures in patients on oral bisphosphonate therapy: an emerging problem.
    Murphy CG; O'Flanagan S; Keogh P; Kenny P
    Acta Orthop Belg; 2011 Oct; 77(5):632-7. PubMed ID: 22187839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Femoral insufficiency fractures associated with prolonged bisphosphonate therapy.
    Isaacs JD; Shidiak L; Harris IA; Szomor ZL
    Clin Orthop Relat Res; 2010 Dec; 468(12):3384-92. PubMed ID: 20809164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate-related femoral periosteal stress reactions: scoring system based on radiographic and MRI findings.
    Png MA; Koh JS; Goh SK; Fook-Chong S; Howe TS
    AJR Am J Roentgenol; 2012 Apr; 198(4):869-77. PubMed ID: 22451554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of incomplete atypical femoral fractures in asymptomatic patients on long-term bisphosphonate therapy.
    La Rocca Vieira R; Rosenberg ZS; Allison MB; Im SA; Babb J; Peck V
    AJR Am J Roentgenol; 2012 May; 198(5):1144-51. PubMed ID: 22528906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is surgery necessary for femoral insufficiency fractures after long-term bisphosphonate therapy?
    Ha YC; Cho MR; Park KH; Kim SY; Koo KH
    Clin Orthop Relat Res; 2010 Dec; 468(12):3393-8. PubMed ID: 20865463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonate-related complete atypical subtrochanteric femoral fractures: diagnostic utility of radiography.
    Rosenberg ZS; La Rocca Vieira R; Chan SS; Babb J; Akyol Y; Rybak LD; Moore S; Bencardino JT; Peck V; Tejwani NC; Egol KA
    AJR Am J Roentgenol; 2011 Oct; 197(4):954-60. PubMed ID: 21940585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Femoral stress fractures associated with long-term bisphosphonate treatment.
    Ward WG; Carter CJ; Wilson SC; Emory CL
    Clin Orthop Relat Res; 2012 Mar; 470(3):759-65. PubMed ID: 22125247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical bisphosphonate-associated subtrochanteric and femoral shaft stress fractures: diagnostic features on bone scan.
    Probst S; Rakheja R; Stern J
    Clin Nucl Med; 2013 May; 38(5):397-9. PubMed ID: 23478849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The advantages of tomosynthesis for evaluating bisphosphonate-related atypical femur fractures compared to radiography.
    Petraszko A; Siegal D; Flynn M; Rao SD; Peterson E; van Holsbeeck M
    Skeletal Radiol; 2016 May; 45(5):615-23. PubMed ID: 26861160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of atypical femoral fractures with bisphosphonate use by patients with varus hip geometry.
    Hagen JE; Miller AN; Ott SM; Gardner M; Morshed S; Jeray K; Alton TB; Ren D; Abblitt WP; Krieg JC
    J Bone Joint Surg Am; 2014 Nov; 96(22):1905-9. PubMed ID: 25410509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cumulative incidence of and risk factors for latent beaking in patients with autoimmune diseases taking long-term glucocorticoids and bisphosphonates.
    Sato H; Kondo N; Wada Y; Nakatsue T; Iguchi S; Fujisawa J; Kazama JJ; Kuroda T; Nakano M; Endo N; Narita I
    Osteoporos Int; 2016 Mar; 27(3):1217-1225. PubMed ID: 26519417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Femoral insufficiency fractures with bisphosphonate therapy. Cases study.
    Boszczyk A; Kowalski D; Zakrzewski P; Pomianowski S
    Ortop Traumatol Rehabil; 2011; 13(4):403-8. PubMed ID: 21857071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of atypical femur stress fracture after discontinuation of bisphosphonate therapy.
    Gu KD; Ettinger B; Grimsrud CD; Lo JC
    Osteoporos Int; 2021 Oct; 32(10):2119-2123. PubMed ID: 33914104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral simultaneous femoral diaphyseal fractures in a patient with long-term ibandronate use.
    Patel VC; Lazzarini AM
    Orthopedics; 2010 Oct; 33(10):775. PubMed ID: 20954650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic intramedullary fixation for bisphosphonate-related subtrochanteric stress fracture.
    Fowler JR; Criner K; Craig MR
    Orthopedics; 2012 Jun; 35(6):e954-7. PubMed ID: 22691674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-operative outcomes of atypical femoral subtrochanteric fracture in patients on bisphosphonate therapy.
    Teo BJ; Koh JS; Goh SK; Png MA; Chua DT; Howe TS
    Bone Joint J; 2014 May; 96-B(5):658-64. PubMed ID: 24788502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Undisturbed local bone formation capacity in patients with atypical femoral fractures: a case series.
    Bögl HP; Aspenberg P; Schilcher J
    Osteoporos Int; 2017 Aug; 28(8):2439-2444. PubMed ID: 28474166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.